VANGUARD GROUP INC - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 32 filers reported holding CHAMPIONS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$426,503
-1.7%
68,680
+1.0%
0.00%
Q2 2023$433,884
+58.7%
68,0070.0%0.00%
Q1 2023$273,388
-10.9%
68,0070.0%0.00%
Q4 2022$306,711
-87.8%
68,007
-79.7%
0.00%
Q3 2022$2,517,000
-9.0%
335,615
-3.0%
0.00%
Q2 2022$2,767,000
-1.6%
345,8430.0%0.00%
Q1 2022$2,812,000
-2.0%
345,843
+0.8%
0.00%
Q4 2021$2,868,000
-14.3%
343,133
+4.7%
0.00%
Q3 2021$3,345,000
-0.7%
327,6360.0%0.00%
Q2 2021$3,368,000
-35.8%
327,636
-29.5%
0.00%
Q1 2021$5,250,000
+12.6%
464,542
+7.5%
0.00%
Q4 2020$4,663,000
-22.0%
432,171
-33.1%
0.00%
Q3 2020$5,978,000
+58.6%
646,162
+63.9%
0.00%
Q2 2020$3,770,000
+77.7%
394,340
+37.5%
0.00%
Q1 2020$2,122,000
-3.9%
286,825
+8.2%
0.00%
Q4 2019$2,209,000
+47.5%
265,188
+0.0%
0.00%
Q3 2019$1,498,000
-27.8%
265,1220.0%0.00%
Q2 2019$2,076,000
-20.0%
265,1220.0%0.00%
Q1 2019$2,596,000
+32.4%
265,122
+5.6%
0.00%
Q4 2018$1,961,000
-51.4%
251,111
+8.6%
0.00%
Q3 2018$4,038,000
+310.4%
231,150
+51.4%
0.00%
Q2 2018$984,000
+77.9%
152,7220.0%0.00%
Q1 2018$553,000
+30.7%
152,722
+40.0%
0.00%
Q4 2017$423,000
+31.0%
109,053
+24.1%
0.00%
Q3 2017$323,000
+66.5%
87,884
+17.4%
0.00%
Q2 2017$194,000
-17.8%
74,8320.0%0.00%
Q1 2017$236,000
+93.4%
74,832
+55.1%
0.00%
Q4 2016$122,000
+351.9%
48,251
+204.6%
0.00%
Q3 2016$27,00015,8400.00%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Battery Management Corp. 2,421,673$26,130,0006.61%
Roubaix Capital, LLC 206,502$2,228,0001.72%
Millrace Asset Group, Inc. 182,337$1,967,0001.37%
NEA Management Company, LLC 1,713,720$18,491,0000.49%
Zebra Capital Management LLC 32,084$346,0000.44%
Overbrook Management Corp 101,445$1,095,0000.27%
EAM Investors, LLC 99,763$1,076,0000.18%
Aristides Capital LLC 40,000$432,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,232$974,0000.12%
Cowen Prime Services LLC 13,500$146,0000.06%
View complete list of CHAMPIONS ONCOLOGY INC shareholders